搜索结果
ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
---|
化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
---|
TCMBANKIN058846 | bergamotin | 380B407; MFCD00017409; SCHEMBL569529; BDBM50310823; AK689401; Bergamotin; Bergomottin; ZINC1658570; NCGC00161832-01; Bergamottin, analytical standard; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-((3,7-dimethyl-2,6-octadienyl)oxy)-, (E)-; JMU611YFRB; C-20280; B3943; Bergamottin; UNII-JMU611YFRB; AC1NV7JD; 7380-40-7; CHEMBL1078442; 5-Geranoxypsoralen; AKOS000277132; 5-Geranyloxypsoralen; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-[[(2E)-3,7-dimethyl-2,6-octadien-1-yl]oxy]-; TNP00285; NCGC00017345-01; 4-([(2E)-3,7-dimethyl-2,6-octadienyl]oxy)-7h-furo[3,2-g]chromen-7-one; DBMJZOMNXBSRED-OQLLNIDSSA-N; CCRIS 8085; CHEBI:70476; MolPort-044-724-380; Bergamotine; 4-[(2E)-3,7-dimethylocta-2,6-dienoxy]furo[3,2-g]chromen-7-one; CJ-26818; Bergaptin; Ambotz7380-40-7; 4-{[(2E)-3,7-Dimethylocta-2,6-dien-1-yl]oxy}-7H-furo[3,2-g]chromen-7-one; NSC710599; NSC-710599; SCHEMBL7183139; MolPort-000-881-227 | C21H22O4 | 338.4 g/mol | CC(=CCCC(=CCOC1=C2C=CC(=O)OC2=CC3=C1C=CO3)C)C |
TCMBANKIN059452 | ethyl aldehyde | C2H4O | 44.05 g/mol | CC=O | |
TCMBANKIN059684 | Vitamin E β- | C29H50O2 | 430.79 | CC1=C(C(=C2CCC(OC2=C1C)(C)CCCC(C)CCCC(C)CCCC(C)C)C)O | |
TCMBANKIN059746 | α-tocopherol | C29H50O2 | 430.7 g/mol | CC1=C(C2=C(CCC(O2)(C)CCCC(C)CCCC(C)CCCC(C)C)C(=C1O)C)C |
疾病ID | 疾病名 | MeSH名 | HPO名 | UMLS名 | 疾病类型 |
---|
TCMBANKDI000054 | Nervous System Diseases; Mental Disorders | Abnormality of the nervous system | Disease or Syndrome | disease | |
TCMBANKDI003248 | Nutritional and Metabolic Diseases; Endocrine System Diseases | Abnormality of metabolism/homeostasis; Abnormality of the endocrine system | Disease or Syndrome | disease | |
TCMBANKDI011173 | Neoplasms | - | Neoplastic Process | disease | |
TCMBANKDI013347 | Pathological Conditions, Signs and Symptoms | Abnormality of metabolism/homeostasis | Disease or Syndrome | disease | |
TCMBANKDI018761 | - | - | Diagnostic Procedure | phenotype | |
TCMBANKDI022394 | - | - | Laboratory Procedure | phenotype | |
TCMBANKDI031192 | Neoplasms; Male Urogenital Diseases | - | Neoplastic Process | disease |